Neuroscience investors
5 investors that name Neuroscience among their sectors are recorded here: 4 venture capital firms and 1 public fund. Stated investment stages run from seed to growth. Most are headquartered in the United States (3) and Australia (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Brandon Capital Partners life science · medical devices · oncology · neuroscience |
Direct investor | Venture capital | Seed – Growth | Melbourne, Australia |
| Forepont Capital Partners artificial intelligence · nanotechnology · neuroscience · biotechnology |
Direct investor | Venture capital | Seed – Series A | New York, United States |
| Massachusetts Life Sciences Center life sciences · biomanufacturing · medtech · women's health |
Direct investor | Public fund | Seed – Growth | Waltham, United States |
| MPM BioImpact biotechnology · drug development · oncology · immunology |
Direct + LP | Venture capital | Seed – Growth | Boston, United States |
| SCI Ventures paralysis · spinal cord injury · biotech · neuroscience |
Direct investor | Venture capital | Seed – Series B |